MEASURING HEALTH-RELATED QUALITY OF LIFE BY EXPERIENCES

Published Apr 10, 2015
Maastricht, The Netherlands - For values of health-related quality of life to be useful in policy, it is crucial that these are measured accurately. Instruments to obtain patient valuations of their own health-related quality of life (HRQOL) usually rely on retrospective self-report. However, due to imperfect recollection of past experiences, these self-reports only partially capture the impact of health problems on the daily lives of people who are affected. In the study “Measuring Health-Related Quality of Life by Experiences: The Experience Sampling Method,” a group of researchers from Maastricht University and the European Centre for Environment and Human Health of the University of Exeter explored the feasibility of measuring HRQOL from moment to moment, in the context of daily life by using the Experience Sampling Method (ESM). They also examined the relationships between momentary feelings and symptoms and valuation of HRQOL and retrospective valuation of HRQOL. The main results of the study showed that the use of the ESM to measure accounts of the momentary experience of health in different populations is feasible. Furthermore, momentary feelings and symptoms were significant predictors of momentary HRQOL, but not of retrospective HRQOL. The authors point out that, “This study highlights that retrospective measures may provide a biased account of the impact of health problems in the daily lives of people who are affected. Therefore ESM may provide a valuable addition to the measurement of HRQOL.”

Related Stories

ISPOR Tackles Health Disparities with New Research Primer

Jan 22, 2025

ISPOR announced today the publication of a report from the ISPOR Health Equity Research Special Interest Group intended to establish key concepts for conducting health equity research that enables investigators to examine—and ultimately reduce—unfair social inequities in health.

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×